Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Introduction

Leptomeningeal metastasis (LM) is a severe complication of solid malignancies, including lung adenocarcinoma, characterized by poor prognosis and diagnostic challenges. This study assesses whether curvilinear peri-brainstem hyperintense signals on MRI are a characteristic feature of LM in lung adenocarcinoma patients.

Methods

This retrospective study analyzed data from multiple centers, encompassing lung adenocarcinoma patients with peri-brainstem curvilinear hyperintense signals on MRI between January 2016 and March 2022. Clinical and radiological data were reviewed, and diagnostic and survival outcomes were analyzed.

Results

Eleven patients (45-76 years; 6 males and 5 females) were included. The mean interval from lung adenocarcinoma diagnosis to detection of brainstem signal was 1.59 years. Four patients had elevated carcinoembryonic antigen levels, and 6 showed systemic metastases. MRI revealed curvilinear hyperintense signals along the pons, medulla, and cerebral peduncles on T2-Weighted Imaging (T2WI), Fluid-Attenuated Inversion Recovery (FLAIR), and Diffusion-Weighted Imaging (DWI). Mild linear enhancement was observed in 4 of 6 patients undergoing contrast-enhanced MRI, and tumor cells were detected in 4 of 6 Cerebrospinal Fluid (CSF) samples. The mean survival time in 7 patients with follow-up data was 3.42 months. Two patients exhibited peri-brainstem calcifications on CT 4–6 months after MRI and died shortly after.

Discussion

These findings suggest that peri-brainstem curvilinear hyperintense signals and mild linear enhancement may serve as radiological markers of LM in lung adenocarcinoma. This pattern may reflect tumor infiltration or secondary changes in the leptomeninges.

Conclusion

Peri-brainstem curvilinear hyperintense signals and mild linear enhancement on T2WI, FLAIR, and DWI may be characteristic of LM in lung adenocarcinoma. These findings suggest further evaluation with contrast-enhanced MRI or CSF analysis for confirmation.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056383570250805110103
2025-08-08
2025-09-19
Loading full text...

Full text loading...

/deliver/fulltext/cmir/21/1/CMIR-21-E15734056383570.html?itemId=/content/journals/cmir/10.2174/0115734056383570250805110103&mimeType=html&fmt=ahah

References

  1. NguyenA. NguyenA. DadaO.T. DesaiP.D. RicciJ.C. GodboleN.B. PierreK. Lucke-WoldB. Leptomeningeal metastasis: A review of the pathophysiology, diagnostic methodology, and therapeutic landscape.Curr. Oncol.20233065906593110.3390/curroncol3006044237366925
    [Google Scholar]
  2. ThakkarJ.P. KumthekarP. DixitK.S. StuppR. LukasR.V. Leptomeningeal metastasis from solid tumors.J. Neurol. Sci.202041111670610.1016/j.jns.2020.11670632007755
    [Google Scholar]
  3. RemsikJ. BoireA. The path to leptomeningeal metastasis.Nat. Rev. Cancer202424744846010.1038/s41568‑024‑00700‑y38871881
    [Google Scholar]
  4. OzcanG. SinghM. VredenburghJ.J. Leptomeningeal metastasis from non–small cell lung cancer and current landscape of treatments.Clin. Cancer Res.2023291112910.1158/1078‑0432.CCR‑22‑158535972437
    [Google Scholar]
  5. WangY. YangX. LiN.J. XueJ.X. Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment.Lung Cancer202217411310.1016/j.lungcan.2022.09.01336206679
    [Google Scholar]
  6. PassarinM.G. SavaT. FurlanettoJ. MolinoA. NortilliR. MussoA.M. ZaninelliM. FranceschiT. OrricoD. MarangoniS. DealisC. GraiffC. FilippoR. GrisantiS. SimonciniE. VassalliL. BerrutiA. PedersiniR. Leptomeningeal metastasis from solid tumors: A diagnostic and therapeutic challenge.Neurol. Sci.201536111712310.1007/s10072‑014‑1881‑725022241
    [Google Scholar]
  7. Le RhunE. WellerM. BrandsmaD. Van den BentM. de AzambujaE. HenrikssonR. BoulangerT. PetersS. WattsC. WickW. WesselingP. RudàR. PreusserM. BoardE.E. CommitteeE.G. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.Ann. Oncol.201728Suppl. 4iv84iv9910.1093/annonc/mdx22128881917
    [Google Scholar]
  8. MitsuyaK. NakasuY. DeguchiS. ShirataK. AsakuraK. NakashimaK. EndoM. TakahashiT. HayashiN. FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: A case series and literature review.Cancer Imaging20202018410.1186/s40644‑020‑00361‑833228799
    [Google Scholar]
  9. YokotaH. MukaiH. HattoriS. OhiraK. HiguchiA. UmedaK. YamauchiS. UnoT. Band-like hyperintensity along the ventral surface of the brain stem on FLAIR and DWI in leptomeningeal carcinomatosis of lung adenocarcinoma.Radiol. Case Rep.202217354454810.1016/j.radcr.2021.11.05434987681
    [Google Scholar]
  10. VenniyoorA. False-negative mri findings for leptomeningeal metastases with use of bevacizumab.J. Thorac. Oncol.2017121510.1016/j.jtho.2016.09.12627988101
    [Google Scholar]
  11. KhilE.K. LeeA.L. ChangK.H. YunT.J. HongH.S. Symmetrical curvilinear cytotoxic edema along the surface of the brain stem.Medicine20159429105310.1097/MD.000000000000105326200611
    [Google Scholar]
  12. MackF. BaumertB.G. SchäferN. HattingenE. SchefflerB. HerrlingerU. GlasM. Therapy of leptomeningeal metastasis in solid tumors.Cancer Treat. Rev.201643839110.1016/j.ctrv.2015.12.00426827696
    [Google Scholar]
  13. TakeiH. RouahE. IshidaY. Brain metastasis: Clinical characteristics, pathological findings and molecular subtyping for therapeutic implications.Brain Tumor Pathol.201633111210.1007/s10014‑015‑0235‑326496727
    [Google Scholar]
  14. de CeusterL.M.E. de BruijnS.F.T.M. HoffmannC.F.E. Miliary cerebral calcifications.Neurology201686987910.1212/WNL.000000000000242426928359
    [Google Scholar]
  15. ResslN. OberndorferS. Multiple calcified brain metastases in a man with invasive ductal breast cancer.BMJ Case Rep.20152015bcr201521177710.1136/bcr‑2015‑211777
    [Google Scholar]
  16. LeeJ.S. MeliskoM.E. MagbanuaM.J.M. KablanianA.T. ScottJ.H. RugoH.S. ParkJ.W. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.Breast Cancer Res. Treat.2015154233934910.1007/s10549‑015‑3610‑126520840
    [Google Scholar]
  17. WilcoxJ.A. ChukwuekeU.N. AhnM.J. AizerA.A. BaleT.A. BrandsmaD. BrastianosP.K. ChangS. DarasM. ForsythP. GarziaL. GlantzM. OlivaI.C.G. KumthekarP. Le RhunE. NagpalS. O’BrienB. PentsovaE. LeeE.Q. RemsikJ. RudàR. SmalleyI. TaylorM.D. WellerM. WefelJ. YangJ.T. YoungR.J. WenP.Y. BoireA.A. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.Neuro-oncol.202426101781180410.1093/neuonc/noae10338902944
    [Google Scholar]
  18. LiangS.K. LiaoW.Y. ShihJ.Y. HsuC.L. YangC.Y. WuS.G. LinY.T. WenY.F. ChenL.C. ChenY.F. ChenY.F. LinY.H. YuC.J. Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis.Neoplasia20256010111310.1016/j.neo.2024.10111339709702
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056383570250805110103
Loading
/content/journals/cmir/10.2174/0115734056383570250805110103
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test